MedPath

The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut Hormones

Not Applicable
Completed
Conditions
Diabetes Mellitus
Registration Number
NCT01997281
Lead Sponsor
Seoul National University Hospital
Brief Summary

The aim of this study is to assess whether dietary fiber-enriched cereals effect on postprandial glucose levels and plasma glucagon-like peptide 1 (GLP-1) and/or glucose-dependent insulinotropic polypeptide (GIP) concentration in patients with type 2 diabetes mellitus.

Detailed Description

Fifteen subjects with type 2 diabetes mellitus will be provided with study meals based on either dietary fiber-enriched cereals or conventional cereals upon two separate admissions in a cross-over fashion. The study meals will be provided at 6 p.m. and 10 p.m. on the day of admission, and 8 a.m. on the next day. A hamburger with coke as mixed meal will be given for lunch at noon on the second day. Blood sampling will be done every 30 minutes from 8 a.m. to 4 p.m. on the second day. The plasma levels of glucose, GLP-1, GIP, insulin, glucagon, and free fatty acid will be measured.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • type 2 diabetes mellitus
  • HbA1c 6.5~8.5%
  • on life style modification or metformin monotherapy at the time of screening
Exclusion Criteria
  • on sulfonylurea or insulin therapy at the time of screening
  • allergy to wheat, flour, other cereals or nuts
  • lactose intolerance
  • pregnancy / lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Area Under the Curve (AUC) of Plasma Total GLP-1 Levels After Intake of the Study Mealevery 30 minutes from 8 a.m. to noon on the second day

To see the changes in the secretion of GLP-1 with dietary fiber enriched cereal, we will calculate the AUC of the plasma total GLP-1 levels.

Secondary Outcome Measures
NameTimeMethod
AUC of Plasma Insulin Levels After Intake of the Study Mealevery 30 minutes from 8 a.m. to noon on the second day
AUC of Plasma Glucagon Levels After Lunchevery 30 minutes from noon to 4 p.m. on the second day
AUC of Plasma Glucose Levels After Intake of the Study Mealevery 30 minutes from 8 a.m. to noon on the second day
AUC of Plasma Total GLP-1 Levels After Lunchevery 30 minutes from noon to 4 p.m. on the second day
AUC of Plasma Total GIP Levels After Intake of the Study Mealevery 30 minutes from 8 a.m. to noon on the second day
AUC of Serum Free Fatty Acid Levels After Intake of the Study Mealevery 30 minutes from 8 a.m. to noon on the second day
AUC of Plasma Total GIP Levels After Lunchevery 30 minutes from noon to 4 p.m. on the second day
AUC of Plasma Glucose Levels After Lunchevery 30 minutes from noon to 4 p.m. on the second day
AUC of Serum Free Fatty Acid Levels After Lunchevery 30 minutes from noon to 4 p.m. on the second day
AUC of Plasma Glucagon Levels After Intake of the Study Mealevery 30 minutes from 8 a.m. to noon on the second day
AUC of Plasma Insulin Levels After Lunchevery 30 minutes from noon to 4 p.m. on the second day

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital
🇰🇷Seoul, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.